M&A Deal Summary

Acino Acquires Norgine - Middle East & North Africa Operations & Product Right

On June 28, 2016, Acino acquired life science company Norgine - Middle East & North Africa Operations & Product Right from Norgine

Acquisition Highlights
  • This is Acino’s 2nd transaction in the Life Science sector.
  • This is Acino’s 1st transaction in the Netherlands.

M&A Deal Summary

Date 2016-06-28
Target Norgine - Middle East & North Africa Operations & Product Right
Sector Life Science
Buyer(s) Acino
Sellers(s) Norgine
Deal Type Divestiture

Target

Norgine - Middle East & North Africa Operations & Product Right

Netherlands
Norgine - Middle East & North Africa Operations & Product Right comprises a business unit that manufactures and markets pharmaceutical products.

Search 204,782 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Acino

Zurich, Czech Republic

Category Company
Founded 1836
Sector Life Science
Employees2,400
DESCRIPTION

Acino is a pharmaceutical company focused on developing, manufacturing and marketing well-proven and innovative pharmaceuticals in novel drug delivery forms. Acino was founded in 1836 and is based in Zurich, Czech Republic.


DEAL STATS #
Overall 2 of 7
Sector (Life Science) 2 of 4
Type (Divestiture) 1 of 5
Country (Netherlands) 1 of 1
Year (2016) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-10-07 Pharma Start

Kyiv, Ukraine

Pharma Start covers the entire value chain from development, manufacturing and registration to distribution, marketing and sales. Pharma Start, the 9th largest local pharmaceutical company in Ukraine.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-11-30 Acino Holding AG - Transdermal Drug Delivery Systems Business

Aesch, Czech Republic

Acino Holding AG - Transdermal Drug Delivery Systems Business includes Acino’s transdermal manufacturing operations in Miesbach, Germany, distribution, and R&D capabilities.

Sell -

Seller(S) 1

SELLER

Norgine

Amsterdam, Netherlands

Category Company
Founded 1906
Sector Life Science
DESCRIPTION

Norgine is an independent specialty pharmaceutical company. Norgine’s focus is the development and marketing of pharmaceutical products that address significant unmet clinical needs in therapeutic areas such as gastroenterology, hepatology, and critical and supportive care. Norgine was formed in 1906 and is based in Amsterdam, Netherlands.


DEAL STATS #
Overall 1 of 2
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
Country (Netherlands) 1 of 1
Year (2016) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-04-01 Endocuff

Leeds, United Kingdom

ARC Medical Design Ltd. is a provider of medical products. ARC Medical Design was founded in 2008 and is based in Leeds, United Kingdom.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-05-11 Merus Labs International

Toronto, Ontario, Canada

Merus Labs International, Inc. is a specialty pharmaceutical company focused on acquiring and optimizing legacy and growth products. The Company leverages its expertise and scalable platform across Europe, Canada and select other markets to deliver value.

Buy $342M